AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+1.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$4.3B
AUM Growth
+$4.3B
(+12%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
11.31%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
319
New
63
Increased
77
Reduced
60
Closed
90
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$97M |
| 2 |
Exact Sciences
EXAS
|
$90.9M |
| 3 |
Icon
ICLR
|
$87.7M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$71.6M |
| 5 |
GSK
GSK
|
$62.7M |
Top Sells
| 1 |
Alkermes
ALKS
|
$40.5M |
| 2 |
PTC Therapeutics
PTCT
|
$38.7M |
| 3 |
Shake Shack
SHAK
|
$34.8M |
| 4 |
Incyte
INCY
|
$29.6M |
| 5 |
Cytokinetics
CYTK
|
$27.5M |
Sector Composition
| 1 | Healthcare | 67.09% |
| 2 | Consumer Discretionary | 10.89% |
| 3 | Consumer Staples | 9.15% |
| 4 | Technology | 8.92% |
| 5 | Communication Services | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Coupang
CPNG
$51.6B
| $7.84M | 0.11% |
+356,872
| New | +$7.84M |
|
|
CMRX
102
DELISTED
Chimerix, Inc.
CMRX
| $7.78M | 0.11% |
2,236,000
+28,000
| +1% | +$97.4K |
|
103
Las Vegas Sands
LVS
$38B
| $7.68M | 0.1% |
149,614
-25,486
| -15% | -$1.31M |
|
104
Scilex Holding
SCLX
$131M
| $7.62M | 0.1% |
17,877,376
+14,367,376
| +409% | +$6.13M |
|
105
Vera Therapeutics
VERA
$1.47B
| $7.54M | 0.1% |
+178,283
| New | +$7.54M |
|
106
Best Buy
BBY
$15.8B
| $7.52M | 0.1% |
+87,677
| New | +$7.52M |
|
107
Target
TGT
$42B
| $7.51M | 0.1% |
55,523
+10,150
| +22% | +$1.37M |
|
108
UiPath
PATH
$5.82B
| $7.14M | 0.1% |
561,907
+71,292
| +15% | +$906K |
|
109
First Watch Restaurant Group
FWRG
$1.12B
| $6.98M | 0.1% |
+375,000
| New | +$6.98M |
|
110
Brinker International
EAT
$7.08B
| $6.68M | 0.09% |
50,528
-102,628
| -67% | -$13.6M |
|
111
Neuropace
NPCE
$310M
| $6.63M | 0.09% |
592,614
+112,614
| +23% | +$1.26M |
|
112
AstraZeneca
AZN
$255B
| $6.55M | 0.09% |
+100,000
| New | +$6.55M |
|
113
Verrica Pharmaceuticals
VRCA
$49.4M
| $6.24M | 0.09% |
+8,921,000
| New | +$6.24M |
|
114
Rockwell Medical
RMTI
$59.6M
| $6.21M | 0.08% |
3,043,678
-537,847
| -15% | -$1.1M |
|
115
Chipotle Mexican Grill
CMG
$56B
| $6.02M | 0.08% |
99,869
-250,949
| -72% | -$15.1M |
|
116
Mural Oncology
MURA
$35.9M
| $5.47M | 0.07% |
1,700,000
| – | – |
|
117
O'Reilly Automotive
ORLY
$88.1B
| $5.35M | 0.07% |
4,515
-2,081
| -32% | -$2.47M |
|
118
VolitionRX
VNRX
$71.6M
| $5.09M | 0.07% |
8,481,895
-516,832
| -6% | -$310K |
|
119
Lamb Weston
LW
$7.88B
| $5.06M | 0.07% |
+75,733
| New | +$5.06M |
|
120
Spyre Therapeutics
SYRE
$1.02B
| $4.66M | 0.06% |
200,000
+64,000
| +47% | +$1.49M |
|
121
Apple Hospitality REIT
APLE
$3.05B
| $4.21M | 0.06% |
+274,407
| New | +$4.21M |
|
122
PVH
PVH
$4.1B
| $4.21M | 0.06% |
+39,784
| New | +$4.21M |
|
123
Rush Street Interactive
RSI
$2.03B
| $3.77M | 0.05% |
275,000
-75,000
| -21% | -$1.03M |
|
124
Zura Bio
ZURA
$132M
| $3.75M | 0.05% |
1,500,000
| – | – |
|
125
FibroGen
FGEN
$48.4M
| $3.6M | 0.05% |
6,800,000
| – | – |
|